Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000019617-25-000501·Intra-Cellular Therapies, Inc.
Schedule 13G ownership disclosure
INTRA-CELLULAR THERAPIES INC
Common Stock, $0.0001 Par Value Per Share · CUSIP: 46116X101
Event date: 2025-05-30
- Filing-level shares
- 0.0
- Percent of class
- 0.0%
- JPMORGAN CHASE & CO.
Shares: 0.0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000501
- Form type
- SCHEDULE 13G/A
- Filer
- Intra-Cellular Therapies, Inc.
- CIK
- CIK 1567514
- Filed
- Jun 05, 2025
- Reporting period
- May 30, 2025
- Description
- Schedule 13G beneficial ownership